APC and malignant colon neoplasm: In particular, early colon cancers commonly display loss of function of the tumor suppressor Adenomatous polyposis coli (APC), a key component of the β-CATENIN destruction complex, or harbor N-terminal gain of function mutations in β-CATENIN that render it APC-resistant.